摘要
目的观察沙丁胺醇联合溴己新治疗慢性组塞性肺疾病稳定期患者的临床疗效。方法选取自2016年4月至2017年4月于我院综合二病房收治的慢性阻塞性肺疾病稳定期的患者60例,采用信封法随机分为试验组和对照组,对照组30例,采用常规内科治疗,试验组30例,在对照组基础上应用沙丁胺醇气雾剂及葡萄糖溴己新注射液静点,观察治疗前后患者肺功能和慢性阻塞性肺疾病疾病评分。结果试验组优于对照组,有统计学差异(P <0.05)。结论沙丁胺醇联合溴己新治疗慢性组塞性肺疾病稳定期患者可以改善肺功能及临床症状,值得推广使用。
Objective To observe the clinical efficacy of salbutamol combined with methyl bromide in the treatment of chronic obstructive pulmonary disease in chronic obstructive pulmonary disease.Methods 60 cases of patients with chronic obstructive pulmonary disease from April 2016 to April 2017 in our hospital two wards,were randomly divided into experimental group and control group using the envelope method,30 cases in the control group received routine medical treatment,experimental group of 30 patients in the control group based on the application of Salbutamol Aerosol and bromhexine glucose a new intravenous injection,observed before and after treatment and pulmonary function of patients with CAT.Results The experimental group was better than the control group,with statistical difference(P<0.05).Conclusion The treatment of chronic obstructive pulmonary disease with salbutamol combined with methyl bromide can improve the pulmonary function and clinical symptoms,so it is worth popularizing.
作者
丁雪
DING Xue(Integrated Second Ward,Dalian Friendship Hospital,Dalian 116001,China)
出处
《中国医药指南》
2018年第29期9-10,共2页
Guide of China Medicine
关键词
沙丁胺醇
葡萄糖溴己新注射液
老年慢性阻塞性肺疾病
Salbutamol
Glucose and methyl bromide injection
Elderly chronic obstructive pulmonary disease